NU/1246 - 8 (2) AELIUS BIOTECH Commercialisation of university research through provision of management skills to assist in successful spin-out company creation
What the buyer wrote
Professor Jeff Pearson and Dr Peter Chater, of Newcastle University, have developed an innovative in vitro model gut system which is currently offered as a research service through the university. The system is the first of its kind capable of integrating a cell culture system with a physiologically accurate mucus layer and whole digestive secretions including bile and digestive enzymes, and has been described as the 'holy grail' of research into oral pharmaceuticals. This system has been used in numerous academic and commercial projects, correctly predicting the outcome of a human ileostomy study and providing contract research services to customers such as Oxford Pharmascience, Suntory Lu…
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- NU/1246 - 8 (2) AELIUS BIOTECH Commercialisation of university research through provision of management skills to assist in successful spin-out company creation
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- services
- Suitable for small firms
- The buyer says yes. What that is worth
- Work starts
- 30 Apr 2018
- Work ends
- 31 Oct 2018
- Kind of work
- Research, evaluation and insight, Pharmacy and medicines
Who the buyer named
University of Newcastle upon Tyne t/a Newcastle University was the named contact on this notice.
